SMAD2 and osteosarcoma: [53] revealed that the up-regulation of miR-1293 enhances cisplatin-induced apoptosis in osteosarcoma cells by inhibiting TIMP1 and its downstream Notch1/Hes1 and TGFBR1/Smad2/3 pathways.